SIRT3 and metabolic dysfunction-associated steatotic liver disease: To summarize, findings from these multiple studies point to the importance of SIRT3 in metabolic disorders such as NAFLD, which has recently been redefined as metabolic dysfunction-associated fatty liver disease (MAFLD) to better reflect the fact that it is a systemic disorder rather than a liver-limited condition [92].